#biosafety cabinet canada
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr Inc. is using 66 technologies for its website.
Text
Biosafety Cabinet Class II B2 LBS2-B21
Labtron Class II B2 Biosafety Cabinet features a 420 mm (17-inch) maximum opening, 100% air exhaust, and ULPA filters with 99.999% efficiency. It includes a motorized anti-UV front window, UV lamp with timer, memory function for power failures, and inflow velocity of 0.53 ± 0.025 m/s.
0 notes
Text
Meticulous Research® Releases New Report on Biopharmaceutical Processing Equipment and Consumables Market: Projected to Reach $83.39 Billion by 2031
Meticulous Research®, a leading global market research company, has published a comprehensive report titled "Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031."
Market Growth Forecast According to the report, the global biopharmaceutical processing equipment and consumables market is projected to grow at a CAGR of 9.5%, reaching $83.39 billion by 2031. The market expansion is driven by initiatives supporting biopharmaceutical adoption, capacity expansions in biopharmaceutical manufacturing plants, and the increasing use of single-use technologies in commercial bioproduction.
Download Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Key Market Players Leading players in this market include:
3M Company (U.S.) Thermo Fisher Scientific, Inc. (U.S.) Bio-Rad Laboratories, Inc. (U.S.) Danaher Corporation (U.S.) Agilent Technologies, Inc. (U.S.) Repligen Corporation (U.S.) Sartorius AG (Germany) Merck KGaA (Germany) Eppendorf AG (Germany) Solaris Biotechnology Srl (Italy) Market Segmentation and Analysis By Product Type The market is segmented into:
Filtration Systems Chromatography Equipment and Consumables Bioreactors Cell Culture Products Mixing Systems Bioprocessing Containers Sterilizers Centrifuges Incubators Shakers Biosafety Cabinets Other Consumables and Accessories Services Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/biopharmaceutical-processing-equipment-and-consumables-market-4200
In 2024, the filtration systems segment is anticipated to hold the largest market share at 22.3%, driven by recurring use in bioprocessing, advancements in filtration technologies, and the rise of single-use filtration systems.
By Application The market is divided into:
Commercial Bioproduction (including Vaccine Manufacturing, mAb Production, Recombinant Protein Production, and Cell and Gene Therapy Production) Research Bioproduction The commercial bioproduction segment is expected to dominate with a 77.5% market share in 2024, fueled by an increasing number of biopharmaceuticals in clinical development and the high demand for monoclonal antibodies.
By End User End users include:
Pharmaceutical and Biopharmaceutical Companies Contract Development and Manufacturing Organizations (CDMOs) Academia and Research Institutes Request Free Sample PDF Copy Here: https://www.meticulousresearch.com/request-sample-report/cp_id=4200 Pharmaceutical and biopharmaceutical companies are projected to hold the largest market share in 2024 due to the high demand for biological products, robust research initiatives, and significant biopharmaceutical production volumes.
Geographic Insights The report provides an in-depth analysis across major geographies:
North America (U.S. and Canada) Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific) Latin America Middle East & Africa In 2024, Europe is expected to lead with a 33.2% market share, driven primarily by Germany’s significant pharmaceutical exports, government support for biotech and biopharmaceutical firms, and capacity expansions for biologics-based drugs.
Quick Buy: https://www.meticulousresearch.com/Checkout/87973509
Key Questions Addressed in the Report What are the high-growth market segments by product type, application, end user, and region? What are the market forecasts and estimates for 2024–2031? Who are the major players and what is the competitive landscape? What are the recent developments and strategies adopted by key market players? For more information, please contact Meticulous Research®.
Contact Information Meticulous Research® Email: [email protected] Phone: +1-646-781-8004 LinkedIn: Meticulous Research
0 notes
Text
Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”
According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.
Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook
The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Consumables & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academia and Research Institutes), and GeographyThe study also evaluates industry competitors and analyzes their market share at global and regional levels.
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.
Based on end user, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in pharmaceutical and biopharmaceutical companies.
Geographic Review:
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa.
Europe is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by North America and Asia-Pacific. Germany is estimated to be the largest shareholding market in Europe in 2022. The growth of this market is primarily driven by the increase in pharmaceutical export, government grants, and funding to biotech and biopharmaceutical companies, and biopharmaceutical companies expanding their capacities for biologics-based drugs and therapeutics to meet the increasing demand of the market. Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4200?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=08-04-2023
Key Players
The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Scope of the Report:
Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Filtration Systems
Chromatography Equipment and Consumables
Consumables
Equipment
Bioreactors
Reusable Bioreactors
Disposable/Single-use Bioreactors
Cell Culture Products
Cell Culture Media
Cell Culture Media, by Physical Form
Dry Powder Media
Liquid Media
Cell Culture Media, by Type
Off-the-Shelf Media
Custom Media
Cell Culture Media, by Source
Chemically Defined Media
Natural Media
Reagents and Supplements
Cell and Cell Lines
Serum
Mixing Systems
Bioprocessing Containers
Sterilizers
Centrifuges
Incubators
Shakers
Biosafety Cabinets
Other Equipment and Consumables
Service (Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)
Biopharmaceutical Processing Equipment and Consumables Market, by Application
Commercial Bioproduction
Vaccine Manufacturing
mAb Production
Recombinant Protein Production
Cell and Gene Therapy Production
Research Bioproduction
Biopharmaceutical Processing Equipment and Consumables Market, by End User
Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Academia and Research Institutes
Biopharmaceutical Processing Equipment and Consumables Market, by Geography
North America
U. S.
Canada
Europe
Germany
U. K.
France
Italy
Spain
Switzerland
Denmark
Ireland
Belgium
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
0 notes
Text
Biopharmaceutical Processing Equipment and Consumables Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Columns, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”
According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.
Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook
The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Systems {Resins, Columns, & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media Market, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research and Development), End User (Biopharmaceutical/ Biotechnology Companies, Contract Development and Manufacturing Organizations and Contract Research Organizations (CDMOs/CROs), & Academics and Research Institutes), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.
Download Free Sample PDF Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=4200
Scope of the Report:
Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Resins
Columns
Equipment
Reusable Bioreactors
Disposable/Single-use Bioreactors
Dry Powder Media
Liquid Media
Off-the-Shelf Media
Custom Media
Chemically Defined Media
Natural Media
(Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)
Global Biopharmaceutical Processing Equipment and Consumables Market, by Application
Vaccine Manufacturing
mAb Production
Recombinant Protein Production
Cell and Gene Therapy Production
Global Biopharmaceutical Processing Equipment and Consumables Market, by End User
Biopharmaceutical/ Biotechnology Companies
Contract Development and Manufacturing Organizations and Contract Research Organizations (CDMOs/CROs)
Academics and Research Institutes
Biopharmaceutical Processing Equipment and Consumables Market, by Geography
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Switzerland
Rest of Europe (RoE)
China
Japan
India
Rest of APAC (RoAPAC)
Speak to Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4200 Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.
Based on application, the market is segmented into commercial bioproduction and R&D. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.
Based on end user, the biopharmaceutical/biotechnology companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in biopharmaceutical/biotechnology companies.
Geographic Review:
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa.
North America is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by Europe and Asia-Pacific. The U.S. is estimated to be the largest shareholding market in North America in 2022. An increase in the biotechnology R&D expenditure, the emergence of infectious diseases, supportive initiatives for increasing adoption of biosimilars, and large number of biopharmaceutical companies are some of the major factors driving the demand for biopharmaceutical processing equipment and consumables in the country.
BUY NOW: https://www.meticulousresearch.com/Checkout/94239620 Key Players
The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Key questions answered in the report-
Which are the high-growth market segments in terms of product type, application, end user, and regions/countries?
What was the historical market for biopharmaceutical processing equipment and consumables across the globe?
What are the market forecasts and estimates for the period 2022–2029?
What are the major drivers, restraints, challenges, opportunities, and trends in the global market of biopharmaceutical processing equipment and consumables?
Who are the major players in the global biopharmaceutical processing equipment and consumables market?
How is the competitive landscape, and who are the market leaders in the global biopharmaceutical processing equipment and consumables market?
What are the recent developments in the biopharmaceutical processing equipment and consumables market?
What are the different strategies adopted by the major players in the biopharmaceutical processing equipment and consumables market?
What are the geographical trends and high growth regions/countries?
top 10 companies operating in Biopharmaceutical Processing Equipment And Consumables Market- https://meticulousblog.org/top-10-companies-in-biopharmaceutical-processing-equipment-and-consumables-market/
Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Connect with us on Twitter- https://twitter.com/MeticulousR123
#Biopharmaceutical Equipment#Biopharmaceutical#Biopharmaceutical Processing#lifescience#Biopharmaceutical Processing Equipment#Biopharmaceutical Processing Equipment and Consumables Market#Biopharmaceutical Processing Equipment and Consumables#healthcare#drug discovery#drug development#medical devices#Filtration#Chromatography#Disposable Bioreactors#Cell Culture Media#Shakers#Vaccine#mAb#health#medical device#medical equipment
0 notes
Text
Across International
As an award-winning, ISO9001:2015 certified lab equipment supplier and manufacturer serving names such as 3M, NIST, GE, Lockheed Martin, NASA, Natural Resources Canada, the US DOE, and all major US national labs & military branches, Across International is well equipped to serve your needs. In addition to standing apart as an exceptional manufacturer of laboratory freezers, refrigerators, biosafety cabinets, furnaces, ovens, distillation equipment, reactors, and more, we partner with the top brands in the industry to offer their products and integrate their components into our solutions designed in-house.. Our expertise covers a wide range of sectors, from medical, pharmaceutical and research laboratories, to 3D printing, nanotechnology, materials research, hemp, cannabis, food and beverage. Our customer base includes Fortune 500 companies, universities, government research teams and small businesses around the world.
1 note
·
View note
Text
Biological Safety Cabinets Market Expected To Cross $13.3 Billion By 2027
The global biological safety cabinets market size is expected to reach USD 282.1 million by 2027, registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Technological advancements due to a rise in laboratory procedures performed that play a crucial role in the safety of personnel, product, and environment, have propelled the market growth. The introduction of smart biosafety cabinets, such as PureLogic+ manufactured by Labconco Inc., with new features and adjustable accessories is playing a crucial role in the growth of the market.
To improve the safety, efficacy, and maintenance, NCBI launched a biological safety cabinet certification program in 2016, which certifies the design, construction, performance, and field parameters of the cabinets. There are various initiatives like the biosafety management programs taken up by the government and private companies that include complete investigation of the cabinets.
Factors like the favorable regulations, increasing prevalence of communicable diseases and rising number of pharmaceutical companies and their R&D activities are anticipated to boost the market growth. However, high product costs and introduction of alternative containment cabinets like the compounding isolators are likely to restrain the market growth.
Request a free sample copy or view report summary: Biological Safety Cabinets Market Report
Biological Safety Cabinets Market Report Highlights
Class II type emerged as the largest product segment in 2019 owing to great efficiency and result delivery of these products
The type A of Class II segment is projected to register the highest CAGR over the forecast period as they offer advantages, such as improved safety
Pharmaceuticals and biopharmaceutical companies had the highest market share due to focus on R&D and innovation by these companies
For instance, in 2018, NuAire launched LabGard ES NU 540, a series of advanced type II biological safety cabinets featuring AeroMax control system and HEPEX zero leak airflow system with dynamic air barrier that allows the technicians to work with precision and efficiency without the risk of contamination
Biological Safety Cabinets Market Segmentation
Grand View Research has segmented the global biological safety cabinets market on the basis of product type, end use, and region:
Biological Safety Cabinets Product Type Outlook (Revenue, USD Million, 2016 - 2027)
Class I
Class II
Class III
Class II Type A
Class II Type B
Biological Safety Cabinets End-use Outlook (Revenue, USD Million, 2016 - 2027)
Pharmaceutical & Biopharmaceutical Companies
Diagnostics & Testing Laboratories
Academic & Research Organizations
Biological Safety Cabinets Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
U.S.
Canada
U.K.
Germany
France
Italy
Spain
The Netherlands
Russia
India
Japan
China
Australia
South Korea
Singapore
Thailand
Brazil
Mexico
Argentina
Colombia
South Africa
Saudi Arabia
UAE
List of Key Companies of Biological Safety Cabinets Market
Thermo Fisher Scientific, Inc.
Labconco Corp.
NuAire, Inc.
The Baker Company, Inc.
Azbil Telstar
Jinan Biobase Biotech Co. Ltd.
Germfree Laboratories, Inc.
Air Science, Inc.
Haier Biomedical (Qingdao Biomedical Co., Ltd.)
Cruma S.A.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Biosafety Cabinet EUROPE Market Research Report 2021-2026
According to this latest study, the 2021 growth of Biosafety Cabinet will have significant change from previous year.
ALSO READ: http://www.marketwatch.com/story/biosafety-cabinet-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2027-2021-07-13
This report presents a comprehensive overview, market shares, and growth opportunities of Biosafety Cabinet market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. Class II A Type Class II B Type Class III Type
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Pharmaceutical Factory Hospital Disease Prevention and Control Academic Research Others
ALSO READ: http://www.marketwatch.com/story/cotton-spinnings-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-07-21
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries
ALSO READ: http://www.marketwatch.com/story/paediatric-radiology-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-07-21
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Esco Lifesciences Group Thermo Fisher Scientific Haier Biomedical NuAire (Polypipe) Telstar Life-Sciences Suzhou Antai Airtech Co., Ltd The Baker Company Kewaunee Scientific Heal Force Bio-Meditech BIOBASE Donglian Har Instrument Faster S.r.l.
Table of Contents
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered
2 Executive Summary 2.1 World Market Overview 2.1.1 Global Biosafety Cabinet Consumption 2016-2026 2.1.2 Biosafety Cabinet Consumption CAGR by Region 2.2 Biosafety Cabinet Segment by Type 2.2.1 Class II A Type 2.2.2 Class II B Type 2.2.3 Class III Type 2.3 Biosafety Cabinet Sales by Type 2.3.1 Global Biosafety Cabinet Sales Market Share by Type (2016-2021) 2.3.2 Global Biosafety Cabinet Revenue and Market Share by Type (2016-2021) 2.3.3 Global Biosafety Cabinet Sale Price by Type (2016-2021) 2.4 Biosafety Cabinet Segment by Application 2.4.1 Pharmaceutical Factory 2.4.2 Hospital 2.4.3 Disease Prevention and Control 2.4.4 Academic Research 2.4.5 Others 2.5 Biosafety Cabinet Sales by Application 2.5.1 Global Biosafety Cabinet Sale Market Share by Application (2016-2021) 2.5.2 Global Biosafety Cabinet Revenue and Market Share by Application (2016-2021) 2.5.3 Global Biosafety Cabinet Sale Price by Application (2016-2021)
3 Global Biosafety Cabinet by Company 3.1 Global Biosafety Cabinet Sales Market Share by Company 3.1.1 Global Biosafety Cabinet Sales by Company (2019-2021) 3.1.2 Global Biosafety Cabinet Sales Market Share by Company (2019-2021) 3.2 Global Biosafety Cabinet Revenue Market Share by Company 3.2.1 Global Biosafety Cabinet Revenue by Company (2019-2021) 3.2.2 Global Biosafety Cabinet Revenue Market Share by Company (2019-2021) 3.3 Global Biosafety Cabinet Sale Price by Company 3.4 Global Manufacturers Biosafety Cabinet Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Biosafety Cabinet Product Location Distribution 3.4.2 Players Biosafety Cabinet Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion
4 Biosafety Cabinet by Region 4.1 Global Biosafety Cabinet by Region 4.1.1 Global Biosafety Cabinet Sales by Region 4.1.2 Global Biosafety Cabinet Revenue by Region 4.2 Americas Biosafety Cabinet Sales Growth 4.3 APAC Biosafety Cabinet Sales Growth 4.4 Europe Biosafety Cabinet Sales Growth 4.5 Middle East & Africa Biosafety Cabinet Sales Growth
5 Americas 5.1 Americas Biosafety Cabinet Sales by Country 5.1.1 Americas Biosafety Cabinet Sales by Country (2016-2021) 5.1.2 Americas Biosafety Cabinet Revenue by Country (2016-2021) 5.2 Americas Biosafety Cabinet Sales by Type 5.3 Americas Biosafety Cabinet Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil
6 APAC 6.1 APAC Biosafety Cabinet Sales by Region 6.1.1 APAC Biosafety Cabinet Sales by Region (2016-2021) 6.1.2 APAC Biosafety Cabinet Revenue by Region (2016-2021) 6.2 APAC Biosafety Cabinet Sales by Type 6.3 APAC Biosafety Cabinet Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia
7 Europe 7.1 Europe Biosafety Cabinet by Country 7.1.1 Europe Biosafety Cabinet Sales by Country (2016-2021) 7.1.2 Europe Biosafety Cabinet Revenue by Country (2016-2021) 7.2 Europe Biosafety Cabinet Sales by Type 7.3 Europe Biosafety Cabinet Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia
8 Middle East & Africa 8.1 Middle East & Africa Biosafety Cabinet by Country 8.1.1 Middle East & Africa Biosafety Cabinet Sales by Country (2016-2021) 8.1.2 Middle East & Africa Biosafety Cabinet Revenue by Country (2016-2021) 8.2 Middle East & Africa Biosafety Cabinet Sales by Type 8.3 Middle East & Africa Biosafety Cabinet Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country
9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends
10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Biosafety Cabinet Distributors 10.3 Biosafety Cabinet Customer
11 Global Biosafety Cabinet Market Forecast 11.1 Global Biosafety Cabinet Forecast by Region 11.1.1 Global Biosafety Cabinet Forecast by Regions (2021-2026) 11.2.2 Global Biosafety Cabinet Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Biosafety Cabinet Forecast by Type 11.7 Global Biosafety Cabinet Forecast by Application
12 Key Players Analysis 12.1 Esco Lifesciences Group 12.1.1 Esco Lifesciences Group Company Information 12.1.2 Esco Lifesciences Group Biosafety Cabinet Product Offered 12.1.3 Esco Lifesciences Group Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Esco Lifesciences Group Main Business Overview 12.1.5 Esco Lifesciences Group Latest Developments 12.2 Thermo Fisher Scientific 12.2.1 Thermo Fisher Scientific Company Information 12.2.2 Thermo Fisher Scientific Biosafety Cabinet Product Offered 12.2.3 Thermo Fisher Scientific Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Thermo Fisher Scientific Main Business Overview 12.2.5 Thermo Fisher Scientific Latest Developments 12.3 Haier Biomedical 12.3.1 Haier Biomedical Company Information 12.3.2 Haier Biomedical Biosafety Cabinet Product Offered 12.3.3 Haier Biomedical Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Haier Biomedical Main Business Overview 12.3.5 Haier Biomedical Latest Developments 12.4 NuAire (Polypipe) 12.4.1 NuAire (Polypipe) Company Information 12.4.2 NuAire (Polypipe) Biosafety Cabinet Product Offered 12.4.3 NuAire (Polypipe) Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 NuAire (Polypipe) Main Business Overview 12.4.5 NuAire (Polypipe) Latest Developments 12.5 Telstar Life-Sciences 12.5.1 Telstar Life-Sciences Company Information 12.5.2 Telstar Life-Sciences Biosafety Cabinet Product Offered 12.5.3 Telstar Life-Sciences Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Telstar Life-Sciences Main Business Overview 12.5.5 Telstar Life-Sciences Latest Developments 12.6 Suzhou Antai Airtech Co., Ltd 12.6.1 Suzhou Antai Airtech Co., Ltd Company Information 12.6.2 Suzhou Antai Airtech Co., Ltd Biosafety Cabinet Product Offered 12.6.3 Suzhou Antai Airtech Co., Ltd Biosafety Cabinet Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Suzhou Antai Airtech Co., Ltd Main Business Overview 12.6.5 Suzhou Antai Airtech Co., Ltd Latest Developments 12.7 The Baker Company
….CONTINUED
CONTACT DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
0 notes
Text
Animal Cell Culture Market 2025 - Consumption Analysis by Risk Factors, Demand and Benefits
3 January 2019 – The Global Animal Cell Culture Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. The process of cultivating cells or tissues outside the body under controlled conditions is known as cell culture. The culture conditions differ depending upon the type of cell. There are primarily three types of cells in culture based on their morphology namely fibroblastic, epithelial-like and lymphoblast-like.
Animal cell culture is one of the key tools used in cellular and molecular biology. It has a number of applications such as to study effects of drugs on cells, cancer research, large production of biological compounds, gene therapy, drug screening & development, and so on.The factors that propel the growth of the Animal Cell Culture Industry include growing demand, technological innovations, rise in research & development undertakings, and increasing investment by life sciences companies. In addition, factors such as growing use of cell culture in wide range of applications such as genetic engineering, cancer diagnosis, stem cell research, drug discovery, etc. also fuel the market growth.
Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/animal-cell-culture-market/request-sample
Animal Cell Culture Industry is classified on applications as biopharmaceutical manufacturing, cytogenetic, gene therapy, tissue culture & engineering, and others. Animal Cell Culture Market is classified on instruments as biosafety cabinets, cryostorage equipment, culture systems, incubators, pipetting instruments, roller bottle equipment, and others. Animal Cell Culture Industry is segmented by distribution channel as online stores, specialty stores and others. Animal Cell Culture Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and African region consists of GCC, South Africa and North Africa.
By geography, North America is projected to hold a major share of the Animal Cell Culture Industry. Some of the key players that fuel the growth of the Animal Cell Culture Market include Atlanta Biologicals, BD, Corning (Cellgro), CellGenix, HiMedia, GE Healthcare, Lonza, PromoCell, Life Technologies, Merck Millipore, Sigma-Aldrich, Thermo Fisher, Takara, Zenbio, and others. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/animal-cell-culture-market
Market Segment:
Key Applications
• Biopharmaceutical Manufacturing
• Tissue Culture & Engineering
• Gene Therapy
• Cytogenetic
Key Regions
· North America
· Europe
· Asia Pacific
· Middle East and Africa
· South America
0 notes
Text
Cell Culture Market to Register a 9.5% CAGR From 2017 to 2025
In a recent report by Transparency Market Research, the cell culture market is rapidly being adopted in the field of pharmaceuticals. Companies managing the global cell culture market are more focused on increasing strategic collaborations and expanding product development worldwide. Furthermore, they are aiming at expanding their footprints in emerging markets such as Latin America and Asia Pacific. An example of such collaboration would be the announcement of collaboration of Valneva SE and GE Healthcare in Nov, 2016 which optimized virus productivity in Valneva’s EB66 cell line. Furthermore, the inauguration of EX-CELL Advanced HD perfusion mediums, is expected to help strengthen the streamline and production of regulatory compliances.
According to TMR, Thermo Fisher Scientific Inc., Dickinson and Company, GE Healthcare, Sartorius AG, and Lonza are some of the leading companies operating in the market. The position in the market is established by leading players and they are enjoying brand loyalty among customers. These manufacturers have extensive distribution network across the world and offer a wide variety of product range. On the back of these factors, they enjoy a stronghold in the global cell culture market.
Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
According to TMR report, the global cell culture market is expected to register a 9.5% CAGR during the forecast period of 2017 to 2025. The valuation of 2016 was around US$13.00 bn and is anticipated to remain stable by the end of the forecast period. Owing to increased focus on Research and Development activities, and the development of healthcare sector and high unmet clinical needs in the region, the cell culture market is expanding with 10.0% CAGR in Asia Pacific.
Increase Use of Stem-Cell Structure to Boost Market
Stem cell culture aids in the stabilization of manufacturing of drugs and allows to produce a wide variety of cell lines and its related products. There is a high potential for growth of the cell culture market with applications like stem cell research in the years to come. Stem cell therapies serve to treat the cause of the disease whereas the old time pharmaceutical therapeutics could only aid in treating the symptoms of the disease. Thus, there is high prospect for the global cell culture market in the field of stem cell culture for developing drugs.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405
Cell structure is considered one of the most important steps in biosimilar production for antibodies. Cell structure reduces manufacturing cost and also increases the productivity and efficiency of biosimilar antibodies.
A majority of manufacturers are persistently trying to expand their product portfolio by launching new and advanced system for large-scale production. This involves both low risk of contamination and is cost-effective providing a win-win situation for the manufacturers.
Strict Regulatory Framework and High Quality Standards Restricting Growth
The imposition of solid regulatory framework and high quality standards set by market leaders may limit the speed of market perforation by newcomers. Furthermore, ethical issues corresponding to the use of high cost of infrastructure, stringent regulations, and fetal bovine serum required for cell culture are expected to hinder the market during the forecast period.
However, there is increase in scope for the use of cell culture in biologics as the research and development in biopharmaceuticals field concentrates on the discovery of new therapeutics for new mechanisms of drug action and rare diseases. Owing to the treatment of chronic diseases in both developing as well as developed countries, there is an increase in demand for cost-effective and efficient products. With this, the demand for approval of biosimilar products have also raised. Due to the rise in demand, the global cell culture market is anticipated to provide lucrative opportunities in the course of the forecast period.
This review is based on the findings of a TMR report titled,” Cell Culture Market (Product – Instruments (Cell Culture Vessels (Bioreactors), Carbon Dioxide Incubators, Biosafety Cabinets, Cryogenic Tanks), Mediums (Chemically Defined Mediums, Classical Mediums, Lysogeny Broths, Serum-free Mediums, Protein-free Mediums, Specialty Mediums), Sera, Reagents (Growth Factors & Cytokines, Albumin, Protease Inhibitors, Thrombin, Attachment Factors, Amino Acids); End use – Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, and Research Institutes) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.”
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/
0 notes
Text
Biosafety Cabinet Class II B2 LBS2-B20
Labtron Biosafety Cabinet Class II B2 features a 0.53 m/s inflow velocity, 770 mm work surface height, ergonomic design, and easy-to-clean stainless steel interior. It offers UV lamp interlock, adjustable base, wind speed control, and remote operation capabilities.
0 notes
Text
Biological Safety Cabinet Market – Highlights On Growing Trends 2025
Global Biological Safety Cabinet Market: Snapshot
Preserving biological samples against contamination, which can be caused merely via exposure to the environment, is paramount for those operating in the fields of pharmaceuticals, biopharmaceuticals, diagnostic and testing laboratories, and research academies. The purpose of protecting against pathogens is adequately served by biological safety cabinet, or simply biosafety cabinet. These enclosed and ventilated devices are developed in various categories, depending on the level of protection they provide. On the back of increased investment on research and development activities, both from public and private domains, the demand for biological safety cabinets is expanding, as per the findings of this business intelligence study. This biosafety cabinet market report has gauged the demand potential for the forecast period of 2017 to 2025.
Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3642
The trend that is restructuring the biological safety cabinet market is quality assurance certification that most of the leading manufacturers are aspiring to gain and install confidence among their prospected customers. For instance, NSF/ANSI 49 is the primary biosafety cabinetry certification, which tests for the basic requirements pertaining to designing and performance of biosafety cabinets and databases information on a product’s environmental protection reliability and durability, noise level control, vibration control, and electrical safety.
Another niche that is emerging in the biological safety cabinet market is widespread adoption of automation across laboratories in terms of preparing and storing samples in a cost effective and time efficient manner.
Strong prevalence of a number of chronic diseases that have urged strong investments on clinical research with favorable governmental policies, rapid growth in the number of biologics, and entrance of several newer innovative players are some of the other factors primed to reflect positively over the global biological safety cabinet market. On the other hand, high cost of the products and the availability of alternative containment cabinets are a few factors curtailing the progress.
Global Biological Safety Cabinet Market: Overview
The global market for biological safety cabinet is going through a significant change where automation is being adopted in laboratories for storage, movement, and preparation of samples and considered to be cost-effective. There is a noticeable shift observed in the market as a high level of human involvement is now being reduced through automation. Safety and precaution in the market is said to be improved due to the use of automation. Rise in automation has helped in increasing the demand for automated laboratories; it has also improved conditions that lead to contamination and reduced the risk of infection.
Request TOC of the Report @
https://www.tmrresearch.com/sample/sample?flag=T&rep_id=3642
Biological safety cabinet could be available in three main types: class I, class II, and class III. As there is a higher risk of foreign agents entering samples and greater probability of contamination through various infections, an improved level of protection through biological safety cabinet is required. Furthermore, rapid automation in the global biological safety cabinet market is expected to make more improved solutions available to end-use industries.
Global Biological Safety Cabinet Market: Trends and Opportunities
The scope for rise in demand for biological safety cabinet could rely on its diverse market categorization and the large number of end users from pharmaceutical and biopharmaceutical companies. Other contributors to the world biological safety cabinet market could be made by testing laboratories, diagnostics, academics, and research institutions since these are areas that require a large amount of testing and researching. Increasing growth in these areas could be due to rising count of research and development institutions, where the need for safety is high as they continuously deal with biological diseases.
Two important classifications of end-use industries using biological safety cabinet could pharmaceuticals and biopharmaceuticals. Swelling demand and automation in the world biological safety cabinet market could benefit the restructuring of laboratories for making them safe for use and free from infections. Introduction of laminar flow, automated air barriers, and emergency biosafety cabinets is said to be one of the vital changes brought about to refine the operation of laboratories.
Global Biological Safety Cabinet Market: Market Potential
In early June 2018, Thermo Fisher Scientific opened its Precision Medicine Science Centre (PMSC) in Cambridge, MA for the U.S. market. The main focus of the center is that it provides ‘omics’ technologies and also exhibits collaboration that will help develop analytical workflow generating precise molecular profiles of patients. The company has also used newer technologies for better development and researching novel ways of treatment. In this regard, it could be said that introduction of new facilities and extension of geographical presence could be leading strategies adopted in the international biological safety cabinet market.
Global Biological Safety Cabinet Market: Regional Outlook
Regional contributions to the international biological safety cabinet market could come from North America, Asia Pacific, and Europe on a high scale. There is a telling increase noted in biomedical research and research and development by pharmaceutical companies in North America, which could make it a larger contributor to the global market. Factors anticipated to support North America’s lead include increasing stem cell research, growing government contribution, support for research in the U.S., and growing government support in protein drug development in Canada. Apart from these specified regions, market growth could also be witnessed in other regions as well.
Read Comprehensive Overview of Report @
https://www.tmrresearch.com/biological-safety-cabinet-market
Global Biological Safety Cabinet Market: Competitive Landscape
With the efforts made through automation and tough competition among small and large players, the market for biological safety cabinet is predicted to see new avenues opening up. The market may go through a phase of stiff competition owing to launch of new products, upgrading of older products, and integration of newer applications in various product offerings. The market could keep experiencing a greater level of competition with growing number of players focusing on securing a larger market share.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: [email protected]
0 notes
Text
Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”
According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.
Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook
The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Consumables & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academia and Research Institutes), and GeographyThe study also evaluates industry competitors and analyzes their market share at global and regional levels.
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.
Based on end user, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in pharmaceutical and biopharmaceutical companies.
Geographic Review:
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa.
Europe is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by North America and Asia-Pacific. Germany is estimated to be the largest shareholding market in Europe in 2022. The growth of this market is primarily driven by the increase in pharmaceutical export, government grants, and funding to biotech and biopharmaceutical companies, and biopharmaceutical companies expanding their capacities for biologics-based drugs and therapeutics to meet the increasing demand of the market. Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4200?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=23-03-2023
Key Players
The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Scope of the Report:
Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Filtration Systems
Chromatography Equipment and Consumables
Consumables
Equipment
Bioreactors
Reusable Bioreactors
Disposable/Single-use Bioreactors
Cell Culture Products
Cell Culture Media
Cell Culture Media, by Physical Form
Dry Powder Media
Liquid Media
Cell Culture Media, by Type
Off-the-Shelf Media
Custom Media
Cell Culture Media, by Source
Chemically Defined Media
Natural Media
Reagents and Supplements
Cell and Cell Lines
Serum
Mixing Systems
Bioprocessing Containers
Sterilizers
Centrifuges
Incubators
Shakers
Biosafety Cabinets
Other Equipment and Consumables
Service (Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)
Biopharmaceutical Processing Equipment and Consumables Market, by Application
Commercial Bioproduction
Vaccine Manufacturing
mAb Production
Recombinant Protein Production
Cell and Gene Therapy Production
Research Bioproduction
Biopharmaceutical Processing Equipment and Consumables Market, by End User
Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Academia and Research Institutes
Biopharmaceutical Processing Equipment and Consumables Market, by Geography
North America
U. S.
Canada
Europe
Germany
U. K.
France
Italy
Spain
Switzerland
Denmark
Ireland
Belgium
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
Download Sample report:https://www.meticulousresearch.com/download-sample-report/cp_id=4200?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=23-03-2023
0 notes
Link
Market Analysis: Global Cleanroom Technology Market
The Global Cleanroom Technology Market accounted to USD 3.67 billion in 2016 growing at a CAGR of 6.12% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Global Cleanroom Technology Market
Cleanroom is a denoted as area or room, which has controlled atmosphere in terms of the level of contamination of dust, airborne particles, microbes, water vapor, and chemical vapors. Cleanroom technology is used in an enclosed space wherein pollutants, contaminants, and airborne particulates are controlled to a specific limit. Cleanroom technology is used for manufacturing aseptic medical goods or for research and development purpose.
Major Market Drivers and Restraints:
Growing demand for better quality healthcare products.
Favorable government initiatives relating to safety and efficacy of healthcare products
Rise in safety concerns
Advancements In Medical Devices
Lack of experienced professionals
High cost associated with maintenance
Market Segmentation: Global Cleanroom Technology Market
The cleanroom technology market is segmented by type into cleanroom equipment and cleanroom consumables. Cleanroom equipment is sub segmented by type into fan filter units (FFU), HVAC systems, laminar air flow systems and biosafety cabinets, HEPA filters, air diffusers and showers.
Cleanroom consumables are sub segmented by type into safety consumables and cleaning consumables. Safety consumable is further sub segmented into apparel, gloves and others. Cleaning consumable is further sub segmented into vacuum systems, wipes, disinfectants and others.
By construction the market is segmented into standard or drywall cleanrooms, hardwall cleanrooms, softwall cleanrooms and terminal boxes or pass-through cabinets.
By end user the market is segmented into pharmaceutical industry, biotechnology industry, medical device manufacturers and hospitals.
On the basis of geography, cleanroom technology market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Cleanroom Technology Market
The cleanroom technology market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cleanroom technology market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Cleanroom Technology Market
Some of the major players operating in cleanroom technology market are
Taikisha Ltd., Azbil Corporation, KCWW, Illinois Tool Works Inc., Royal Imtech, Ardmac, E. I. du Pont de Nemours and Company, Clean Air Products, M+W Group, Alpiq Group, Ansell, The Camfil Group, Helapet Ltd., Nicomac Srl, Simplex Isolation Systems, AIRTECH JAPAN, Ltd., Takasago International Corporation, AdvanceTEC, iClean Technologies Inc., CRT Cleanroom-Technology GmbH, Lennox Clean Room Technologies, Hemair, BMF Unternehmensgruppe, COLANDIS GmbH, AES CLEAN TECHNOLOGY, INC. and ABN Cleanroom Technology among others.
Research Methodology: Global Cleanroom Technology Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst call or drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
#Global Cleanroom Technology Market#Cleanroom Technology#Cleanroom Technology Market#Global Cleanroom Technology Market Size#Global Cleanroom Technology Market Share#Global Cleanroom Technology Market Overview#Global Cleanroom Technology Market Opportunities#Global Cleanroom Technology Market Trends#Global Cleanroom Technology Market Growth#Global Cleanroom Technology Market Key Players
0 notes
Text
Cell Culture Market : Competitive Strategies And Forecasts to 2025
Global Cell Structure Market: Snapshot
Pharmaceuticals industry is adopting the cell structure trend at a rapid pace. The removal of living cells from an animal or a plant and developing these cells in a controlled and artificial environment is called the process of cell structure. The market for cell structure is anticipated to draw more revenue with major players concentrating on research and development in biopharmaceuticals field.
Major vendors of the cell structure market are stressing more on expansion of their product and using strategies that can help in collaborations in order to have a strong foothold in the entire market. Asia Pacific and Latin America are regions with the most potential hence, players are developing collaboration programs in order to establish their market in the aforementioned areas.
Obtain Report Details @
https://www.transparencymarketresearch.com/cell-culture-market.html
The launch of new and advanced system is expected to boost the global cell structure market in the long run especially for production on a large-scale basis. The advantages of this is that it is cost efficient as well as retains a very low contamination risk. This serves as a great deal to the players of cell structure market.
However, factors like the high standard quality set by leaders of the market and solid regulatory framework imposition may act as a hindrance to the overall growth of the market in the future years. In addition to that, strict regulations, and fetal bovine serum that is required for cell structure production are also envisioned to restrict the market growth. Besides, ethical rules and regulations proportional to using high expenditure in terms of infrastructure is also seen as a restraining factor for the future growth of the market.
Nevertheless, due to the fact that both developing as well as developed nations are putting more focus on treating chronic diseases, the cell structure market will soon see a rapid growth as there is more demand for cost efficient and effective products in the market.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
The global cell structure market was worth a US$ 13.0 Bn in 2016 and is presumed to expand at a 10.0% CAGR within the forecast period of 2017 to 2025.
Chemically Defined Mediums Adaptation to Boost Market Growth
Owing to the rising trend approaching the usage of component-free, and animal-derived mediums and the acceptance of specialty and chemically defined mediums, the global cell structure market is yet to witness remarkable growth in the coming years.
The global cell structure market is classified on the basis of end user and product. As per the classification of end user, the global cell structure market is divided into research institutes, academic institutes, pharmaceutical companies, and biotechnology companies.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405
On the basis of product, the market is segmented into reagents, sera, mediums, and instruments. Further classification of instruments are cryogenic tanks, biosafety cabinets, carbon dioxide incubators, and cell culture vessels (Bioreactors). Further segmentation of mediums are specialty mediums, protein-free mediums, serum-free mediums, lysogeny broths, classical mediums, and chemically defined mediums. Sera is further categorized into Fetal Bovine Serum (FBS). Reagents are further segmented into amino acids, attachment factors, thrombin, protease inhibitors, albumin, and growth factors & cytokines.
Asia Pacific to Increase Market Revenue with Rise in Outsourcing Activities
The global cell structure market is studied on the basis of key geographies Latin America, Middle East and Africa, Europe, Asia Pacific, and North America. Asia Pacific is anticipated to boost the market in the coming years owing to the rise in manufacturing of biopharmaceuticals and increase in outsourcing activities over the region.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]
0 notes
Text
Animal Cell Culture Market Segmentation Application, Technology and Market Analysis Research Report 2025
28th September 2018: Global Animal Cell Culture Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are increasing across the globe. The process of cultivating cells or tissues outside the body under controlled conditions is known as cell culture. The culture conditions differ depending upon the type of cell. There are primarily three types of cells in culture based on their morphology namely fibroblastic, epithelial-like and lymphoblast-like.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/animal-cell-culture-market
Animal cell culture is one of the key tools used in cellular and molecular biology. It has a number of applications such as to study effects of drugs on cells, cancer research, large production of biological compounds, gene therapy, drug screening & development, and so on. The factors that propel the growth of the Animal Cell Culture Industry include growing demand, technological innovations, rise in research & development undertakings, and increasing investment by life sciences companies. In addition, factors such as growing use of cell culture in wide range of applications such as genetic engineering, cancer diagnosis, stem cell research, drug discovery, etc. also fuel the market growth.
On the other hand, there are also factors that may hamper the growth of the market such as requirement of skilled labor, stringent rules & regulation for process manufacturing and high cost of cell culture media. Animal Cell Culture Market is classified on the basis of product type, applications, instruments, distribution channel and geography. Animal Cell Culture Market is segmented by product type as classical media & salts, serum-free media, stem cell media and others.
Animal Cell Culture Industry is classified on applications as biopharmaceutical manufacturing, cytogenetic, gene therapy, tissue culture & engineering, and others. Animal Cell Culture Market is classified on instruments as biosafety cabinets, cry storage equipment, culture systems, incubators, pipetting instruments, roller bottle equipment, and others. Animal Cell Culture Industry is segmented by distribution channel as online stores, specialty stores and others. Animal Cell Culture Market is classified on the basis of geography as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and African region consists of GCC, South Africa and North Africa.
By geography, North America is projected to hold a major share of the Animal Cell Culture Industry. Some of the key players that fuel the growth of the Animal Cell Culture Market include Atlanta Biologicals, BD, Corning (Cellgro), CellGenix, HiMedia, GE Healthcare, Lonza, PromoCell, Life Technologies, Merck Millipore, Sigma-Aldrich, Thermo Fisher, Takara, Zenbio, and others. The key players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/animal-cell-culture-market/request-sample
0 notes
Text
Cell Culture Market To Expand At A Robust CAGR Of 9.5% From 2017 To 2025
The global cell culture market was valued at around US$ 13,000.0 Mn in 2016 and is anticipated to register a stable CAGR of over 9.5% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The global cell culture market is likely to be driven by development of new products, technological advancements, and increasing use of single-use bioprocessing systems during the forecast period. The cell culture market in Asia Pacific is expanding at a CAGR of above 10.0%, due to high unmet clinical needs, development of the health care sector, and increased focus on R&D activities in the region.
Increasing Demand and Approvals for Biosimilar Products and Other Biologic Therapeutics to drive the Market
Cell culture is one of the most important steps in the production of biosimilar antibodies, as cell culture helps increase the efficiency and productivity and reduces the cost of manufacture. Increasing demand and approvals for biosimilar products and other biologic therapeutics for the treatment of chronic diseases in developed as well as developing countries has augmented the demand for efficient and cost-effective products. This rising demand is, in turn, anticipated to drive the global cell culture market during the forecast period. Moreover, increasing demand for cost-effective and highly efficient cell culture products such as bioreactors, mediums, reagents, and sera for the production of high-yield cell lines has led to increase in the number of new product launches. This factor is anticipated to provide lucrative opportunities to the global cell culture market during the forecast period. Major manufactures are constantly trying to expand their product portfolio by launching new and advanced systems for large-scale production which is cost-effective and which involves low risk of contamination. For instance, in 2018, Merck launched capsule filters that are designed to decrease the risk of contamination in a bioreactor. These filters are used for separation of mycoplasma and bacteria from cell culture mediums. However, ethical issues associated with the use of fetal bovine serum, stringent regulations, and high cost of infrastructure required for cell culture are expected to hamper the global cell culture market during the forecast period.
Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Technological Advancements in Cell Culture Production Mediums and Instruments are likely to fuel the Demand for Protein-based Therapeutics
Based on product, the global cell culture market has been categorized into instruments, mediums, sera, and reagents. The instruments segment has been sub-categorized into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. Technological advancements for improving the efficiency and reducing the risk of cross contamination are expected to drive the instruments segment during the forecast period. The mediums segment has been sub-segmented into chemically defined mediums, classical mediums, protein-free mediums, lysogeny broths, serum-free mediums, and specialty mediums. High efficiency of different mediums used for cell culture production is anticipated to drive the mediums segment during the forecast period. The sera segment has been sub-divided into fetal bovine serum and others. Sera are used as cell culture supplements consisting of growth factors, nutrients, and other important trace elements. The reagents segment has been sub-categorized into albumin, amino acids, attachment factors, growth factors & cytokines, protease inhibitors, thrombin, and others. Applications such as stem cell research offer high potential for growth of the cell culture market in the near future. Stem cell culture assists in the standardization of drug production and enables production of a wide variety of cell lines and related products. Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Thus, further research in the field of stem cell culture for the development of drugs offers high potential for the market in the near future.
Request Report For Discount: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=405
Increasing Research and Development Expenditure to fuel Pharmaceutical Companies Segment
In terms of end-user, the global cell culture market has been divided into biotechnology companies, pharmaceutical companies, academic institutes, and research institutes. The pharmaceutical companies segment dominated the cell culture market in 2016. The trend is anticipated to continue during the forecast period as well. The segment is expected to hold more than 29.0% of the market share by 2025. Growth of the segment is attributable to increasing number of biotechnology companies and rising strategic collaborations among market players to expand the presence worldwide. The pharmaceutical companies segment is likely to be followed by the biotechnology companies segment during the forecast period.
Increasing Focus of Key Players in Asia Pacific on Creation of more Opportunities for Cell Culture Market
Geographically, the global cell culture market has been divided into major five geographical regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major share of the market during the forecast period, owing to presence of key players in the region, increasing research and development activities, and new drug approvals. Shift in trend toward continuous processing is also anticipated to drive the cell culture market in North America from 2017 to 2025. The Asia Pacific cell culture market was valued at around US$ 2,900.0 Mn in 2016 and is anticipated to witness significant growth from 2017 to 2025. Increasing focus of key players on expansion in the Asia Pacific region, large untapped population, and rising awareness about health care promote the growth of the cell culture market in Asia Pacific. For instance, in 2016, Thermo Fisher expanded its Fisher BioServices and cryogenic service facilities in Japan.
Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=405
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
0 notes